Call Us:  +1.302.777.7774

CECON logo

Log in

Login to your account

Username *
Password *
Remember Me
Show More
Add this resume to contact form Yes No
Back to Search Result GO

Organic Medicinal Chemist with Expertise in the Synthesis and Design of Medicinal Drug Candidates

Technical Consultant #1784


  • Medicinal Chemist with a proven track record of success in the synthesis and design of medicinal drug candidates.
  • Provide creative and innovative solutions to chemistry challenges including the safe design, conduct, interpretation and technical evaluation.
  • Significant synthetic research experience in multi-step milligram to multigram quantities of intermediates and products, diversity design, crystallographic modeling and experience with protein-protein interactions.
  • Molecule design in partnership with pharmacology and moving projects forward in a collaborative, dynamic team setting.
  • Establish new areas of intellectual property for therapeutic targets in drug discovery design.
  • Manage and communicate scientific results in a personable and scientific format while providing strong analytical skills.
  • SAR, structure design for favorable pharmacological properties.
  • Patent searching and evaluation for competitive intelligence.
  • Chemical toxicology in human and the environment (marine and agricultural).


  • LCMS, GCMS, automated column chromatography, HPLC, IR and NMR spectroscopy from microgram to kilogram scale reactions.
  • Researcher and co-inventor for over twenty-five patent applications and patents are in areas of oncology, Alzheimer's disease, analgesia and neuronal protection and enhancements.
  • Continuous flow reactors, reverse phase HPLC analytical methods and supercritical fluid chromatography (SFC).


Undisclosed Company, Executive Director and Consultant, 2012 - Present

  • Oversee a Biotechnology business centering on innovation in academia and industry on a global platform.
  • Promote and implement lab safety architecture at contract institutions.
  • Establish, plan, and prioritize the overall IT goals and strategies for the organization.
  • Early stage product development.
  • Consults within The CECON Group, Idea Connection and academic institutions.

West Chester University, West Chester, PA, Professor of Chemistry, 2012 - 2014

Chemistry and Heterocylic Chemistry Research

  • Convene, educate and engage key constituencies on chemistry to achieve course objectives and implications of developing/expanding the consumer footprint.

Ursinus College, Collegeville, PA, Professor, 2013 - 2013

  • Environmental Chemistry and Medicinal Chemistry Project (OIDD).

IdeaConnection, Victoria, BC, Canada, 2011 - 2012

  • Problem solver: Identify, review, and troubleshooting for bacterial control challenge.

Hoffmann-La Roche, Nutley, NJ, Research Scientist, 2007 - 2011

  • Design innovative synthetic scaffolds for oncology drug candidates.
  • Synthesis of novel pyrrolidine scaffold for MDM2-p53 protein-protein interaction.
  • Compound currently in Pre-Clinical Development as new generation Nutlin for clinical candidate.
  • Understand and make design choices that fit the strategic context while keeping in mind the company culture.
  • Recognized value levers of information technology adoption, including business process automation, information science, collaboration and mobility. On the leading edge of understanding advanced technologies and practices (training staff).
  • Demonstrated thought leadership in creating and capturing value through platforms, networks, experimentation and co-creation while being a team player. Able to deal with strategic, technical and change management issues.
  • Adept at managing diverse relationships across expertise, geography and culture.
  • Synthesis of novel pyrrolidine scaffold for MDM2-p53 protein-protein interaction. Compound currently in Pre-Clinical Development as new generation Nutlin for clinical candidate.
  • Proficient at NMR for proton, fluorine, carbon and 2D experiments. Routinely use HPLC for preparative work (Gilson), Analogix for column chromatography purification, LCMS, Genevac for library synthesis, LIMS, GC/GCMS.
  • Diversity design and parallel synthesis to increase productivity and success of analogs.
  • Active in utilizing computer programs to find trends in SAR (Spotfire, WebStar, and PDT).
  • Utilized skills in patent intelligence, including defensive patent strategy for Roche MDM2 program.
  • Evaluated flow technology and trained scientists on H-Cube Technology (ThalesNano) for discovery chemistry.

Johnson & Johnson PRD, LLC, Spring House, PA, Research Scientist, 1994 - 2007

  • Design innovative synthetic scaffolds for CNS and analgesia drug candidates.
  • Create and foster a collaborative atmosphere.
  • Focused on outcomes (moving the business forward) while working as a trusted agent, acting with integrity. Open and receptive to listening and discerning pain points. Leader with ideas, evidence and examples derived by experimentation.
  • Responsibility Statement: Explore and optimize synthetic routes for CNS and Analgesic drug candidates.
  • Design and synthesis of secretase modulators for the treatment of Alzheimer's disease.
  • Created novel 2-Aminoquinolines and other scaffolds as - secretase Inhibitors for the treatment of Alzheimer's disease.
  • Initiated and implemented library design of ORL-1 partial and full agonists, core member of Discovery Team for novel series in clinical development.
  • Cross-site collaboration on neuroprotection project and ORL-1 project.
  • Discovered the first small molecule galanin receptor antagonist, currently used as an academic research standard.
  • Received Vision Award for ORL-1Opioid Agonist research in clinical development.

Sterling Winthrop PDR, Collegeville, PA, Research Scientist, 1990 - 1994

  • Responsibility Statement: Designed organic syntheses for anti-inflammatory drug candidates, including IL 1- drug candidate that went to preclinical trials at Vertex/Aventis.
  • Using knowledge, imagination, skill, diversity and teamwork to build business value.
  • Establishment of a capability-driven intellectual property portfolio resulting in end to end processes to connect customer and product.

SmithKline Beecham, King of Prussia, PA, Medicinal Chemist, 1988 - 1990

  • Responsibility Statement: Synthesized Angiotensin II Receptor Antagonists for cardiovascular research.

Honors & Publications


Focused Studies

  • Novel Enantioselective Synthesis of a Bicyclo[2.2.2]octane Scaffold Targeting the Natural Product (-)-Atisine, Bryn Mawr College.
  • Stereospecific Tandem Cyclization for the Synthesis of Silphiperfolene and Atom Transfer Cyclization of Stabilized Radicals, University of Pittsburgh

Academic and Professional Affiliations

  • Roche Excellence in Chemistry Symposium
  • ACS Metro Women Chemists Committee
  • The Scientific Research Society Sigma Xi
  • American Association for the Advancement of Science

Publications and Patents

  • Over 30 publications and presentations submitted.
  • 25 total issued and pending patents.


  • Ph.D. Organic Chemistry, Bryn Mawr College, Bryn Mawr, PA
  • M.S. Organic Chemistry, University of Pittsburgh, Pittsburgh, PA
  • B.S. Chemistry, University of Maryland, College Park, MD
Back to Search Result GO